Collectively, our study shows that NUF2 is likely to be a meaningful gene in the occurrence and development of ccRCC and an effective biomarker for the diagnosis and prognostic assessment of ccRCC. The gene discussed is NUF2; the disease is nonpapillary renal cell carcinoma.